CrizotinibAcquired drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1958卷 / 1期

关键词：

D O I：

10.1007/s40278-023-39841-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[21] Alectinib/ceritinib/crizotinibAcquired resistance: case report
Reactions Weekly, 2022, 1901 (1) : 28 - 28
[22] CrizotinibAcquired resistance in metastatic lung cancer: case report
Reactions Weekly, 2015, 1536 (1) : 73 - 73
[23] Ceritinib/crizotinibAcquired drug resistance: 10 case reports
Reactions Weekly, 2019, 1771 (1) : 85 - 85
[24] Ceritinib/crizotinibAcquired resistance to crizotinib, nausea, vomiting and increased transaminases: case report
Reactions Weekly, 2019, 1734 (1) : 123 - 123
[25] CrizotinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2014, 1500 (1) : 15 - 15
[26] CrizotinibAcquired resistance to crizotinib in non-small lung cancer: case report
Reactions Weekly, 2017, 1648 (1) : 103 - 103
[27] Cabozantinib/capmatinib/crizotinibAcquired resistance: 6 case reports
Reactions Weekly, 2021, 1850 (1) : 84 - 84
[28] Ceritinib/crizotinibAcquired resistance to crizotinib and ceritinib by an L1152R mutation: case report
Reactions Weekly, 2016, 1617 (1) : 57 - 57
[29] CrizotinibAcquired resistance to crizotinib
Reactions Weekly, 2022, 1887 (1) : 234 - 234
[30] Alectinib/crizotinibAcquired resistance to alectinib and crizotinib in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1707 (1) : 23 - 23

← 1 2 3 4 5 →